ROOLIFE GROUP LTD — Director's Dealing 2018

Dec 11, 2018

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Open DNA Limited
ABN	14 613 410 398

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Evan Cross
Date of last notice	15 November 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct/Indirect interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Sante Holdings Pty Ltd ATF DEC Family A/C (an entity on which Mr Cross holds a beneficial interest)
Date of change	11 December 2018
No. of securities held prior to change	200,005 Ordinary Shares 1,200,000 unlisted options exercisable at $0.30 each on or before 9 September 2019 900,000 unlisted options exercisable at $0.35 each on or before 30 June 2021 900,000 unlisted options exercisable at $0.40 each on or before 30 June 2023
Class	Fully Paid Ordinary Shares
Number acquired	771,964

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$27,019
No. of securities held after change	971,969 Ordinary Shares 1,200,000 unlisted options exercisable at $0.30 each on or before 9 September 2019 900,000 unlisted options exercisable at $0.35 each on or before 30 June 2021 900,000 unlisted options exercisable at $0.40 each on or before 30 June 2023
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	Issue of fully paid ordinary shares to settle outstanding director fees.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	N/A
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Open DNA Limited
ABN	14 613 410 398

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Grant Pestell
Date of last notice	15 November 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct/Indirect interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Mr GA and Mrs B Pestell ATF Pestell Superannuation Fund. Mr Pestell owns 25% of Digrevni Investments Pty Ltd (Digrevni). Mr Pestell also has a 25% interest in Artemis Corporate Limited (Artemis) and a 24% interest in Storm Enterprises Pty Ltd (Storm). None of the above entities are controlled by Mr Pestell [, nor does he have the capacity to determine their ability to dispose of securities they hold from time to time].
Date of change	11 December 2018

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	250,005 fully paid ordinary shares 2,000,000 unlisted options exercisable at $0.30 each on or before 9 September 2019 1,500,000 unlisted options exercisable at $0.35 each on or before 30 June 2021 1,500,000 unlisted options exercisable at $0.40 each on or before 30 June 2023
Class	Fully Paid Ordinary Shares and Unlisted Options
Number acquired	1,864,107 shares via their issue to Artemis Corporate pursuant to Shareholder approval 3,049,624 shares via the disclosure of a relevant interest in Digrevni, Artemis and Storm. 3,500,000 unlisted options exercisable at $0.05 on or before 31 October 2021
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$65,243.75 relevant to the issue to Artemis Corporate Nil consideration for the 3,049,624 fully paid ordinary shares (relates to disclosure of a relevant interest only). Nil consideration for the options.
No. of securities held after change	5,163,736 fully paid ordinary shares 2,000,000 unlisted options exercisable at $0.30 each on or before 9 September 2019 1,500,000 unlisted options exercisable at $0.35 each on or before 30 June 2021 1,500,000 unlisted options exercisable at $0.40 each on or before 30 June 2023 3,500,000 unlisted Options exercisable at $0.05 on or before 31 October 2021

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of fully paid ordinary shares to settle outstanding director fees. Disclosure of relevant interest in other entities.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	N/A
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3